Advertisement
Advertisement
U.S. markets open in 2 hours 56 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Treace Medical Concepts, Inc. (TMCI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
23.24+0.37 (+1.62%)
At close: 04:00PM EDT
23.24 0.00 (0.00%)
After hours: 04:10PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close22.87
Open22.91
Bid0.00 x 800
Ask0.00 x 800
Day's Range22.57 - 23.56
52 Week Range12.48 - 26.20
Volume204,924
Avg. Volume288,039
Market Cap1.288B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.52
Earnings DateNov 02, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est28.75
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for TMCI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Treace Medical Concepts, Inc.
    Daily – Vickers Top Buyers & Sellers for 08/30/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    last monthArgus Research
View more
  • GlobeNewswire

    Treace Medical Concepts Appoints New Directors

    PONTE VEDRA, Fla., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions), today announced the appointment of Lance E. Berry and Jane E. Kiernan to its board of directors, effective October 1, 2022. “With decades of combined experience leading medical device companies, Lance and Jane strengthen the expertise of our

  • Benzinga

    Treace Medical Shares Interim Data From Corrective Toe Surgery Trial

    Treace Medical Concepts Inc (NASDAQ: TMCI) announced an audio poster presentation of the latest interim analysis from the ALIGN3D clinical study following the Lapiplasty Procedure for surgical treatment of hallux valgus (bunions). The data showed: Early return to weight bearing in a walking boot at an average of 8.3 days. A low recurrence rate, defined as loss of radiographic correction, was observed in 1.4% of patients (2 out of 144). An 81% reduction in pain (Visual Analog Scale) was reported

  • GlobeNewswire

    Treace Highlights New Product Innovations at the 2022 AOFAS Scientific Conference

    PONTE VEDRA, Fla., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions), announces it will highlight new product innovations at the 2022 American Orthopaedic Foot & Ankle Society (AOFAS) Annual Meeting in Quebec City, Canada from September 14-17.1 Several technologies will be highlighted at Treace’s booth (No. 30

Advertisement
Advertisement